Interleukin-18, also known as interferon-gamma inducing factor is a protein which in humans is encoded by the IL18 gene. The protein encoded by this gene is a proinflammatory cytokine. From Wikipedia
Penn researchers report 81% response rates and durable remissions in refractory B-cell lymphoma using huCART19-IL18, a next-generation CAR T therapy with a rapid manufacturing process.